Freeze-Dried Cell Bio-Ink Structures for High-Density 3D Printing
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current bioprinting technologies are limited by low cell density, slow mass transport, poor geometric control, and inefficient nutrient acquisition, leading to bio-inks and printed structures with limited functionality and geometric constraints, primarily restricted to two-dimensional (2D) structures.
Innovation Solution
The use of bio-inks comprising freeze-dried cells, particularly microbes, with high cell densities and dual filler components such as nanocellulose, enhances cell density and geometric control, enabling three-dimensional (3D) structures with improved mass transport and nutrient acquisition.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Quantity of substance
If conventional bioprinting technologies are used, then cell density is low, but this limits mass transport and nutrient acquisition efficiency
Solution Approach 1:
The patent changes the physical state of cells from liquid suspension to freeze-dried solid particles, fundamentally altering the bio-ink's rheological properties. This parameter change enables high cell density (up to 90 wt%) while maintaining printability and improving mass transport through the solid particulate network structure
Solution Approach 2:
The patent creates a composite bio-ink system combining freeze-dried cell particles with hydrogel matrices and binding agents. This composite structure allows simultaneous achievement of high cell density, structural integrity, and enhanced mass transport pathways through the composite material architecture
2Manufacturing precision
If conventional bioprinting is used, then geometric control is poor, but this restricts structures to primarily 2D configurations
Solution Approach 1:
The patent enables transition from 2D to 3D structures by utilizing the unique rheological properties of freeze-dried cell-based bio-inks. The solid particulate nature allows vertical stacking and complex 3D geometry fabrication with high precision, overcoming the dimensional limitations of conventional liquid-based bioprinting
Solution Approach 2:
The patent segments the bio-ink into discrete freeze-dried cell particles that can be precisely positioned and deposited layer-by-layer. This segmentation enables superior geometric control and complex 3D architecture fabrication while maintaining cell viability through the gentle freeze-drying process
3Quantity of substance
If high cell density is achieved, then nutrient acquisition becomes inefficient, but this limits functional performance
Solution Approach 1:
The patent utilizes the porous structure inherent in freeze-dried cell particles and the inter-particle spaces in the bio-ink to create efficient nutrient transport pathways. The porous architecture allows nutrient diffusion and mass transport even at high cell densities, resolving the contradiction between cell quantity and nutrient acquisition efficiency
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The high cell density and dual filler bio-inks maintain cell viability and metabolic activity for extended periods, allowing for the creation of 3D structures with tunable intracellular distances and customizable geometries, facilitating applications in biosensing, tissue regeneration, and catalysis.
Implementation Method 1
bio-inks comprised of a filler of freeze-dried cells
Data Source
AI summary
Bio-ink comprising freeze-dried cells, methods of making a living structure from a bio-ink material of freeze-dried cells, and methods of using the living structure for biosensing, tissue regeneration, environment sensing, drug discovery, catalysis, and/or clinical implementation are described herein.